γ-Aminobutyric acid and glutamate dysregulation in the dorsolateral prefrontal cortex of adolescents with first-episode major depressive disorder and the modulatory effects of repetitive transcranial magnetic stimulation

首次发作重度抑郁症青少年背外侧前额叶皮层中γ-氨基丁酸和谷氨酸失调及其重复经颅磁刺激的调节作用

阅读:1

Abstract

BACKGROUND: Major depressive disorder (MDD) is associated with dysregulation of γ-aminobutyric acid (GABA) and glutamate(Glu) neurotransmission in the prefrontal cortex. Proton magnetic resonance spectroscopy (1H-MRS) enables non-invasive in vivo quantification of GABA and Glx(glutamate + glutamine) levels. This study investigated neurochemical characteristics of the bilateral dorsolateral prefrontal cortex (DLPFC) in first-episode adolescent MDD (FEA-MDD) and repetitive transcranial magnetic stimulation (rTMS)'s impact on these changes. METHODS: 42 drug-naïve FEA-MDD patients underwent bilateral DLPFC MRS scans before and after rTMS, with 42 healthy controls (HCs) as baseline. All participants were right-handed. The Mescher-Garwood point-resolved spectroscopy (MEGA-PRESS) protocol detected GABA+ (GABA plus macromolecules and high carnosine) and Glx levels, processed via Gannet software. RESULTS: FEA-MDD patients exhibited significantly lower GABA+ and higher Glx levels in the left DLPFC than HCs; in the right DLPFC, no significant difference in GABA+ levels was observed, though Glx levels were elevated. After rTMS treatment, GABA+ levels in the left DLPFC increased significantly, whereas Glx levels showed a non-significant decreasing trend. Additionally, HCs had no hemispheric differences, while in FEA-MDD, the left DLPFC showed lower GABA+ and Glx levels compared to the right. We also found that in the left DLPFC, baseline GABA+ levels were negatively correlated with Hamilton Depression Scale (HAMD) scores; Glx levels showed positive correlations with scores on the Ruminative Response Scale (RRS), Self-Rating Depression Scale (SDS), and Self-Esteem Scale (SES). CONCLUSIONS: FEA-MDD involves prefrontal GABA+/Glx dysregulation, and rTMS may aid in restoring neurotransmitter balance within the DLPFC. This study adds to the expanding body of evidence supporting the application of targeted neurochemical modulation in the treatment of FEA-MDD, while also providing insights into potential intervention mechanisms.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。